All In MedTech

FDA Clearance Tracker · P180031-S002

Neuroform Atlas® Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 18, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180031-S002
Device name
Neuroform Atlas® Stent System
Applicant location
Fremont, CA
Received
Aug 21, 2019
Decided
Jan 18, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P180031

Device type

Device class
Class III

Every decision under product code QCA

FDA's approval statement

As written in FDA's record.

Approval of the revised protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Stryker Neurovascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.